Interestingly, 3AC treatment de-stabilizes SHIP1 protein expression via the Ubiquitin-proteasome system, but not SHIP2, in multiple myeloma cells, providing further evidence of its selectivity [19]. The gene discussed is INPP5D; the disease is AL amyloidosis.